Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Wellness Devices May Have More Leeway In FDA Final Guidance

Executive Summary

As new mobile health technologies such as wearables and mobile health apps come to market, the US FDA's new guidance is intended to give manufacturers a better idea of what kinds of low-risk wellness products the agency will allow to avoid regulation.


Related Content

Get 'HIP'AA To Digital Medtech Law: More Than Just FDA To Worry About
mHealth Regs: FDA Drafts Wellness, Accessories Guidance Docs





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts